260 related articles for article (PubMed ID: 20116693)
1. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM
J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
3. Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model.
Yun JI; Wikesjö UM; Borke JL; Bisch FC; Lewis JE; Herold RW; Swiec GD; Wood JC; McPherson JC
J Clin Periodontol; 2010 May; 37(5):419-26. PubMed ID: 20236187
[TBL] [Abstract][Full Text] [Related]
4. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats.
Komrakova M; Stuermer EK; Werner C; Wicke M; Kolios L; Sehmisch S; Tezval M; Daub F; Martens T; Witzenhausen P; Dullin C; Stuermer KM
Bone; 2010 Sep; 47(3):480-92. PubMed ID: 20580683
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T
Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071
[TBL] [Abstract][Full Text] [Related]
6. Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model.
Lin EA; Liu CJ; Monroy A; Khurana S; Egol KA
J Orthop Trauma; 2012 Dec; 26(12):719-23. PubMed ID: 22932751
[TBL] [Abstract][Full Text] [Related]
7. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures.
Andreassen TT; Ejersted C; Oxlund H
J Bone Miner Res; 1999 Jun; 14(6):960-8. PubMed ID: 10352105
[TBL] [Abstract][Full Text] [Related]
8. [Intermittent low-dose administration of recombinant human parathyroid hormone (1-34) promotes the expression of Runx2 during early stage of fracture healing].
Li N; Wang MY; He L; Jiang X; Wu CA
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):771-6. PubMed ID: 19595108
[TBL] [Abstract][Full Text] [Related]
9. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures.
Tägil M; McDonald MM; Morse A; Peacock L; Mikulec K; Amanat N; Godfrey C; Little DG
Bone; 2010 Mar; 46(3):852-9. PubMed ID: 19922821
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34).
Alkhiary YM; Gerstenfeld LC; Krall E; Westmore M; Sato M; Mitlak BH; Einhorn TA
J Bone Joint Surg Am; 2005 Apr; 87(4):731-41. PubMed ID: 15805200
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model.
Abe Y; Takahata M; Ito M; Irie K; Abumi K; Minami A
Bone; 2007 Nov; 41(5):775-85. PubMed ID: 17707711
[TBL] [Abstract][Full Text] [Related]
12. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
Lane NE; Thompson JM; Strewler GJ; Kinney JH
J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).
Nakajima A; Shimoji N; Shiomi K; Shimizu S; Moriya H; Einhorn TA; Yamazaki M
J Bone Miner Res; 2002 Nov; 17(11):2038-47. PubMed ID: 12412812
[TBL] [Abstract][Full Text] [Related]
15. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase.
Andreassen TT; Willick GE; Morley P; Whitfield JF
Calcif Tissue Int; 2004 Apr; 74(4):351-6. PubMed ID: 15255072
[TBL] [Abstract][Full Text] [Related]
16. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora.
Komatsubara S; Mori S; Mashiba T; Nonaka K; Seki A; Akiyama T; Miyamoto K; Cao Y; Manabe T; Norimatsu H
Bone; 2005 Apr; 36(4):678-87. PubMed ID: 15781006
[TBL] [Abstract][Full Text] [Related]
17. Strong effect of PTH (1-34) on regenerating bone: a time sequence study in rats.
Skripitz R; Andreassen TT; Aspenberg P
Acta Orthop Scand; 2000 Dec; 71(6):619-24. PubMed ID: 11145391
[TBL] [Abstract][Full Text] [Related]
18. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone.
Tang ZL; Zhang WJ; Wang DX; Chen JM; Ma H; Wu DR
J Oral Maxillofac Surg; 2014 Feb; 72(2):419-30. PubMed ID: 24071373
[TBL] [Abstract][Full Text] [Related]
19. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.
Andreassen TT; Fledelius C; Ejersted C; Oxlund H
Acta Orthop Scand; 2001 Jun; 72(3):304-7. PubMed ID: 11480610
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.
Morgan EF; Mason ZD; Bishop G; Davis AD; Wigner NA; Gerstenfeld LC; Einhorn TA
Bone; 2008 Dec; 43(6):1031-8. PubMed ID: 18761113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
